IL151170A0 - Embryonic stem cells and neural progenitor cells derived therefrom - Google Patents

Embryonic stem cells and neural progenitor cells derived therefrom

Info

Publication number
IL151170A0
IL151170A0 IL15117001A IL15117001A IL151170A0 IL 151170 A0 IL151170 A0 IL 151170A0 IL 15117001 A IL15117001 A IL 15117001A IL 15117001 A IL15117001 A IL 15117001A IL 151170 A0 IL151170 A0 IL 151170A0
Authority
IL
Israel
Prior art keywords
embryonic stem
derived therefrom
neural progenitor
stem cells
progenitor cells
Prior art date
Application number
IL15117001A
Other languages
English (en)
Original Assignee
Es Cell Int Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ6211A external-priority patent/AUPQ621100A0/en
Priority claimed from AUPR1279A external-priority patent/AUPR127900A0/en
Priority claimed from AUPR2920A external-priority patent/AUPR292001A0/en
Application filed by Es Cell Int Pte Ltd filed Critical Es Cell Int Pte Ltd
Publication of IL151170A0 publication Critical patent/IL151170A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
IL15117001A 2000-03-14 2001-03-14 Embryonic stem cells and neural progenitor cells derived therefrom IL151170A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPQ6211A AUPQ621100A0 (en) 2000-03-14 2000-03-14 Embryonics stem cells and neural progenitor cells derived therefrom
AUPR1279A AUPR127900A0 (en) 2000-11-06 2000-11-06 Embryonic stem cells and neural progenitor cells derived therefrom 2)
AUPR2920A AUPR292001A0 (en) 2001-02-06 2001-02-06 Embryonic stem cells and neural progenitor cells derived therefrom (3)
PCT/AU2001/000278 WO2001068815A1 (en) 2000-03-14 2001-03-14 Embryonic stem cells and neural progenitor cells derived therefrom

Publications (1)

Publication Number Publication Date
IL151170A0 true IL151170A0 (en) 2003-04-10

Family

ID=27158213

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15117001A IL151170A0 (en) 2000-03-14 2001-03-14 Embryonic stem cells and neural progenitor cells derived therefrom
IL204766A IL204766A (en) 2000-03-14 2010-03-25 Embryonic stem cells and nerve cells derived from them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL204766A IL204766A (en) 2000-03-14 2010-03-25 Embryonic stem cells and nerve cells derived from them

Country Status (6)

Country Link
US (8) US7504257B2 (xx)
EP (2) EP1263932A4 (xx)
JP (1) JP4889902B2 (xx)
CA (1) CA2403000C (xx)
IL (2) IL151170A0 (xx)
WO (1) WO2001068815A1 (xx)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US20050042749A1 (en) * 2001-05-16 2005-02-24 Carpenter Melissa K. Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
EP1263932A4 (en) 2000-03-14 2004-06-23 Es Cell Int Pte Ltd EMBRYONIC CELLS AND NEURONAL STEM CELLS DERIVED THEREFROM
US7011828B2 (en) * 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
US7250294B2 (en) * 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
JP5943533B2 (ja) * 2000-05-17 2016-07-06 アステリアス バイオセラピューティクス インコーポレイテッド 神経前駆細胞の集団
AU2004214542B2 (en) * 2000-05-17 2007-08-16 Asterias Biotherapeutics, Inc. Neural progenitor cell populations
AU2001292618A1 (en) * 2000-09-12 2002-03-26 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
EP1491093B1 (en) 2001-02-14 2013-07-31 ABT Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2002078449A2 (en) * 2001-04-02 2002-10-10 Advanced Cell Technology, Inc. Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
WO2003014320A2 (en) 2001-08-10 2003-02-20 Cornell Research Foundation, Inc. Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
WO2003018783A1 (en) * 2001-08-23 2003-03-06 Reliance Life Sciences Pvt., Ltd ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
US6887706B2 (en) 2001-10-03 2005-05-03 Wisconsin Alumni Research Foundation Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells
CA2465653C (en) * 2001-10-30 2013-10-08 Renomedix Institute Inc. Method for inducing differentiation of mesodermal stem cells, es cells, or immortalized mesodermal stem cells into neural cells
EP1448763A4 (en) * 2001-11-09 2006-11-29 Es Cell Int Pte Ltd CHARACTERIZATION AND ISOLATION OF SUBSETS OF HUMAN EMBRYONIC STEM CELLS (HES) AND CELLS ASSOCIATED THERETO OR DERIVED THEREFROM
WO2003055992A2 (en) * 2001-12-28 2003-07-10 Cellartis Ab A method for the establishment of a pluripotent human blastocyst-derived stem cell line
WO2003067904A2 (en) * 2002-02-06 2003-08-14 University Of North Carolina At Chapel Hill High-throughput cell identification and isolation method and apparatus
WO2003078610A1 (en) * 2002-03-20 2003-09-25 Miltenyi Biotec Gmbh A method for generating human nervous system cells, tissues, or neural stem cell progenitors from haematopoietic stem cells
EP2360241A1 (en) 2002-06-05 2011-08-24 ES Cell International Pte Ltd. Stem cells
JP4439396B2 (ja) * 2002-06-24 2010-03-24 田辺三菱製薬株式会社 神経系細胞の製造方法
US7285415B2 (en) * 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US20050101014A1 (en) 2002-07-11 2005-05-12 Keirstead Hans S. Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US7390659B2 (en) * 2002-07-16 2008-06-24 The Trustees Of Columbia University In The City Of New York Methods for inducing differentiation of embryonic stem cells and uses thereof
WO2004013606A2 (en) 2002-08-02 2004-02-12 Stratatech Corporation Species specific dna detection
JP4118877B2 (ja) 2002-10-22 2008-07-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 分裂停止後のドーパミン産生ニューロン前駆細胞に特異的に発現している遺伝子
PT2457999T (pt) 2002-12-16 2019-01-28 Technion Res & Dev Foundation Sistema de cultura para células estaminais pluripotentes
AU2004219851B2 (en) * 2003-03-12 2009-12-17 Reliance Life Sciences Pvt. Ltd. Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
WO2005003320A2 (en) 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
US7776584B2 (en) * 2003-08-01 2010-08-17 Genetix Limited Animal cell colony picking apparatus and method
US20050106725A1 (en) * 2003-11-19 2005-05-19 Palecek Sean P. Method of reducing cell differentiation
ES2491891T3 (es) 2004-01-16 2014-09-08 Carnegie Mellon University Marcaje celular para técnicas de resonancia magnética nuclear
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US7670596B2 (en) * 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
US20050272149A1 (en) 2004-06-02 2005-12-08 Life & Brain Gmbh Therapeutic delivery of adenosine into a tissue
WO2005118785A1 (en) 2004-06-02 2005-12-15 Es Cell International Pte Ltd Cell preservation method
GB2414995B (en) 2004-06-09 2006-11-15 Univ Edinburgh Neural stem cells
US8492147B2 (en) 2004-06-18 2013-07-23 Riken Method of inducing the differentiation of embryonic stem cells into nerve by serum-free suspension culture
US8597947B2 (en) * 2004-12-29 2013-12-03 Hadasit Medical Research Services & Development Limited Undifferentiated stem cell culture systems
US20090104695A1 (en) * 2004-12-29 2009-04-23 Etti Ben Shushan Stem Cells Culture Systems
WO2006086746A2 (en) 2005-02-09 2006-08-17 Burnham Institute For Medical Research Homogeneous neural precursor cells
WO2006110806A2 (en) * 2005-04-12 2006-10-19 The Trustees Of The University Of Pennsylvania Multipotent adult stem cells
US8476070B2 (en) 2005-08-29 2013-07-02 Technion Research & Development Foundation Limited Media for culturing stem cells
JP2009533684A (ja) * 2006-04-14 2009-09-17 カーネギー・メロン・ユニバーシティ 核磁気共鳴技術のための細胞標識及び定量
JP2009533061A (ja) * 2006-04-14 2009-09-17 セルセンス， インコーポレイテッド 細胞の標識を評価する方法
CA2646491A1 (en) * 2006-04-17 2007-10-25 Bioe, Inc. Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
KR100838013B1 (ko) * 2006-06-07 2008-06-12 제일약품주식회사 인간배아줄기세포로부터 단계적 선별법을 통해 고수율로신경전구세포, 신경세포 및 기능성 도파민신경세포를생성하는 방법
WO2008011070A2 (en) * 2006-07-19 2008-01-24 Reprocure, Llc A method of oocyte cryopreservation including piercing the zona pellucida prior to vitrification
US9040297B2 (en) 2006-08-02 2015-05-26 Technion Research & Development Foundation Limited Methods of expanding embryonic stem cells in a suspension culture
EP2064319B1 (en) * 2006-08-28 2017-02-22 Yeda Research and Development Co. Ltd. Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
US8785193B2 (en) * 2006-09-14 2014-07-22 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Dissection tool and methods of use
US9005964B2 (en) 2006-11-24 2015-04-14 Regents Of The University Of Minnesota Endodermal progenitor cells
EP2139497B1 (en) * 2007-04-13 2013-11-06 Stemnion, INC. Methods for treating nervous system injury and disease
WO2009009105A2 (en) * 2007-07-10 2009-01-15 Carnegie Mellon University Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
EP2192908A4 (en) * 2007-07-25 2010-09-01 Bioe Inc DIFFERENTIATION OF PRECURSOR CELLS OF MULTIPLE ABSTRACTS AGAINST CHONDROCYTES
US8338176B2 (en) * 2007-07-30 2012-12-25 The Board Of Trustees Of The Leland Stanford Junior University Derivation of neural stem cells from embryonic stem cells
SG188096A1 (en) 2008-01-30 2013-03-28 Geron Corp Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
JP5751708B2 (ja) * 2008-05-02 2015-07-22 セルセンス， インコーポレイテッド 核磁気共鳴技法および他の用途のためのエマルジョンを生成するための組成物ならびに方法
WO2009143241A2 (en) * 2008-05-21 2009-11-26 Bioe, Inc. Differentiation of multi-lineage progenitor cells to pancreatic cells
EP3187581A1 (en) 2008-12-23 2017-07-05 BOCO Silicon Valley, Inc. Target populations of oligodendrocyte precursor cells and methods of making and using same
WO2010096496A2 (en) 2009-02-17 2010-08-26 Memorial Sloan-Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
JP5783504B2 (ja) * 2009-03-30 2015-09-24 国立研究開発法人国立環境研究所 胎生プログラミングに対する影響を評価するための方法
US20110052549A1 (en) * 2009-08-27 2011-03-03 The Regents Of The University Of California Cell culture device to differentiate stem cells in a specific orientation
WO2011041062A1 (en) * 2009-10-02 2011-04-07 University Of Southern California Cranial neural crest stem cells and culture condition that supports their growth
CA2783437C (en) 2009-11-12 2020-08-04 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
KR20120102709A (ko) 2009-11-17 2012-09-18 어드밴스드 셀 테크놀로지, 인코포레이티드 인간 ｒｐｅ 세포의 생산 방법 및 인간 ｒｐｅ 세포의 제약 제제
WO2011091944A1 (en) 2010-01-26 2011-08-04 Université Libre de Bruxelles Tools for isolating and following cardiovascular progenitor cells
HUE039900T2 (hu) * 2010-03-22 2019-02-28 Stemina Biomarker Discovery Inc Gyógyszerek humán fejlõdésre gyakorolt toxicitásának elõrejelzése humán õssejtszerû sejtek és metabolomika alkalmazásával
CA2795815C (en) 2010-04-23 2018-06-26 Cold Spring Harbor Laboratory Novel structurally designed shrnas
CN101914492A (zh) * 2010-06-08 2010-12-15 辽宁中医药大学 表达抗炎细胞因子il-10的骨髓源神经干细胞的制备方法
EP3549617B1 (en) 2010-07-12 2023-09-13 University of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
KR102099807B1 (ko) * 2011-01-12 2020-04-14 츠네오 키도 시험관 내 조건에서 희돌기아교-계통 세포로 분화하는 경향이 있는 포유류의 신경줄기세포 및／또는 신경선조세포의 순수 또는 농축 세포군을 수득하고 유지하는 세포배양방법
US20120270314A1 (en) * 2011-04-19 2012-10-25 Buddhist Tzu Chi General Hospital Non-tumorigenic expansion of pluripotent stem cells
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
CA2875858C (en) 2011-06-21 2022-05-03 Georgia Tech Research Corporation Adhesive signature-based methods for the isolation of stem cells and cells derived therefrom
WO2013022584A1 (en) 2011-08-05 2013-02-14 Corning Incorporated Modulation of the mammalian receptor mtor to inhibit stem cell differentiation into neurons
PT2773748T (pt) 2011-11-04 2020-03-26 Memorial Sloan Kettering Cancer Center Neurónios dopaminérgicos (da) do mesencéfalo para enxerto
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
WO2013131012A1 (en) * 2012-03-01 2013-09-06 University Of Miami Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues
EP3498824A1 (en) 2013-04-26 2019-06-19 Memorial Sloan-Kettering Cancer Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
KR102483685B1 (ko) 2013-11-21 2023-01-03 메모리얼 슬로안 케터링 캔서 센터 인간 다능성 줄기 세포로부터 기능적 두개 기원판 유도체의 전문화
JP6304818B2 (ja) * 2014-04-21 2018-04-04 花王株式会社 皮膚由来多能性前駆細胞の作製方法
KR101793722B1 (ko) 2014-08-25 2017-11-03 한국생명공학연구원 성상세포의 생산방법
WO2017141831A1 (ja) * 2016-02-16 2017-08-24 ロート製薬株式会社 脂肪組織由来間質細胞を含む虚血性疾患治療剤およびその製造方法
US11920155B2 (en) 2016-03-30 2024-03-05 Asterias Biotherapeutics, Inc. Oligodendrocyte progenitor cell compositions
WO2018107135A1 (en) * 2016-12-09 2018-06-14 Neoneuron Llc Method of treating neurological disorders with stem cell therapy
JP2020526212A (ja) * 2017-07-13 2020-08-31 アリール バイオテクノロジー アンド ファーマシューティカルズ， インコーポレイテッド ランドマーク転写因子を使用した幹細胞分化による神経前駆細胞、オリゴデンドロサイト前駆細胞、およびオリゴデンドロサイトの誘導
JP7469317B2 (ja) 2019-01-23 2024-04-16 アステリアス バイオセラピューティクス インコーポレイテッド ヒト多能性幹細胞からの背側由来オリゴデンドロサイト前駆細胞
EP3983531A1 (en) 2019-06-12 2022-04-20 Hadasit Medical Research Services and Development Ltd. Methods of generating oligodendrocytes
WO2023278382A1 (en) 2021-06-29 2023-01-05 Staffan Holmin Endoluminal delivery cannula
WO2023201361A1 (en) 2022-04-15 2023-10-19 Aspen Neuroscience, Inc. Methods of classifying the differentiation state of cells and related compositions of differentiated cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200148A (en) 1988-01-11 1993-04-06 Fuji Photo Film Co., Ltd. Chemical assay tape
US5672499A (en) * 1992-07-27 1997-09-30 California Institute Of Technology Immoralized neural crest stem cells and methods of making
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
DE19756864C5 (de) * 1997-12-19 2014-07-10 Oliver Brüstle Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten
US6875607B1 (en) * 1998-11-09 2005-04-05 Es Cell International Pte Ltd Embryonic stem cells
WO2000055312A2 (en) 1999-03-17 2000-09-21 The University Of Tennessee Research Corporation Rt-pcr of clonal neurospheres
AU4328500A (en) 1999-03-30 2000-10-16 Myelos Corporation Retro-inverso prosaposin-derived peptides and use thereof
EP1179046B1 (en) * 1999-05-07 2006-03-08 University Of Utah Research Foundation Lineage-restricted precursor cells isolated from mouse neural tube and mouse embryonic stem cells
JP2003520725A (ja) 2000-01-07 2003-07-08 エフ・エム・シー・テクノロジーズ・インク 能動力反動システム及び受動減衰を有する係船システム
US7011828B2 (en) 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
AU2005200148B2 (en) 2000-03-14 2007-12-20 Es Cell International Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
EP1263932A4 (en) 2000-03-14 2004-06-23 Es Cell Int Pte Ltd EMBRYONIC CELLS AND NEURONAL STEM CELLS DERIVED THEREFROM
JP5943533B2 (ja) 2000-05-17 2016-07-06 アステリアス バイオセラピューティクス インコーポレイテッド 神経前駆細胞の集団

Also Published As

Publication number Publication date
US8137969B2 (en) 2012-03-20
IL204766A (en) 2014-07-31
JP2004500103A (ja) 2004-01-08
EP2453010A1 (en) 2012-05-16
US8460931B2 (en) 2013-06-11
US20020068045A1 (en) 2002-06-06
US20090258421A1 (en) 2009-10-15
EP1263932A1 (en) 2002-12-11
US20120122109A1 (en) 2012-05-17
WO2001068815A1 (en) 2001-09-20
US7947498B2 (en) 2011-05-24
US7504257B2 (en) 2009-03-17
US20060078543A1 (en) 2006-04-13
CA2403000C (en) 2015-06-23
US20050260747A1 (en) 2005-11-24
US20130330821A1 (en) 2013-12-12
US20090075373A1 (en) 2009-03-19
US20120115229A1 (en) 2012-05-10
CA2403000A1 (en) 2001-09-20
JP4889902B2 (ja) 2012-03-07
EP1263932A4 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
IL204766A (en) Embryonic stem cells and nerve cells derived from them
AU2002301347A1 (en) Embryonic stem cells and neural progenitor cells derived therefrom
IL152106A0 (en) Embryonic stem cells, neural progenitor cells derived therefrom and methods for the preparation thereof
MXPA02003733A (es) Metodos para producir celulas progenitoras diferenciadas y celulas troncales embrionicas de lineas de descendencia defectivas.
AU7924501A (en) Progenitor cells and methods and uses related thereto
IL142748A0 (en) Embryonic stem cells
GB2392674B (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
IL153095A0 (en) Embryonic stem cells, methods for culturing the same and methods utilizing the same
GB2399572B (en) Hematopoietic cells from human embryonic stem cells
IL145002A0 (en) Adipose-derived stem cells and lattices
IL156234A0 (en) Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
GB2379447B (en) Neural progenitor cell populations
IL188472A0 (en) Islet cells from human embryonic stem cells
AU8617301A (en) Directed differentiation of embryonic cells
IL144654A0 (en) Pancreatic progenitor cells, methods and uses related thereto
EP1299168A4 (en) MINI SWIRL SEPARATOR AND THICKENER FOR BIOMASS
EP1447443A4 (en) IMMORTALIZED MESENCHYMAL CELLS AND USE THEREOF
AU6438901A (en) Protein translocation into plant cells
AU1154802A (en) Single cell electroporation
EP1115841A4 (en) STABLE CELL LINES FROM NEURAL STEM CELLS
GB0006125D0 (en) Fuel cells
HUP0501094A2 (en) Somatic cell derived embryonic stem cells and its differentiated cells
AUPR127900A0 (en) Embryonic stem cells and neural progenitor cells derived therefrom 2)
HK1046360A1 (zh) 有nade，p75ntr-聯系細胞死亡執行編碼的基因及其使用
AUPQ621100A0 (en) Embryonics stem cells and neural progenitor cells derived therefrom

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed